Marque Millennium Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Marque Millennium Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$3.04M	Hold	53,820	–	–	2.17%	14
2015 Q2	$3.18M	Hold	53,820	–	–	1.61%	23
2015 Q1	$3.35M	Hold	53,820	–	–	1.32%	32
2014 Q4	$3.1M	Hold	53,820	–	–	1.22%	34
2014 Q3	$2.89M	Hold	53,820	–	–	1.16%	39
2014 Q2	$2.82M	Hold	53,820	–	–	1.12%	40
2014 Q1	$2.84M	Hold	53,820	–	–	1.19%	37
2013 Q4	$2.16M	Hold	53,820	–	–	0.95%	48
2013 Q3	$2.03M	Hold	53,820	–	–	1%	47
2013 Q2	$2.11M	Buy	+53,820	New	+$2.1M	1.11%	43

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marque Millennium Capital Management's TEVA Position: Q3 2015 in Review

Marque Millennium Capital Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2015 at 53,820 shares worth $3.04M. The position accounts for 2.17% of the portfolio, ranked #14.

Marque Millennium Capital Management first reported a position in TEVA in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.35M in Q1 2015. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Marque Millennium Capital Management held 53,820 shares of Teva Pharmaceuticals worth $3.04M as of Q3 2015.
Marque Millennium Capital Management left its Teva Pharmaceuticals share count unchanged in Q3 2015.
Teva Pharmaceuticals made up 2.17% of Marque Millennium Capital Management's portfolio in Q3 2015, its #14 holding.
Marque Millennium Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Marque Millennium Capital Management's Teva Pharmaceuticals position peaked at $3.35M in Q1 2015.
824 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Marque Millennium Capital Management's 13F filing for Q3 2015, filed 3 Nov 2015.